Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Recurring [Member] Fair Value, Recurring [Member] Warrant liabilities Warrants and Rights Outstanding Schedule of Changes in Level 3 Warrant Liabilities Measured at Fair Value [Abstract] Balance ending Balance beginning Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Change in fair value Fair Value, Option, Changes in Fair Value, Gain (Loss) Fair value at issuance Net proceeds warrants Proceeds from Issuance of Warrants Exercise of warrants Proceeds from warrant exercises Proceeds from Warrant Exercises Angel Warrants [Member] Angel Warrants Member Avenue Warrants [Member] Avenue Warrants Member Hudson Warrants [Member] Hudson Warrants Member Contractual term (years) [Member] Measurement Input, Expected Term [Member] Risk-free rate [Member] Measurement Input, Risk Free Interest Rate [Member] Probability assessment [Member] Measurement Input Probability Assessments Member Class of Warrant or Right [Domain] Investor Warrants [Member] Investor Warrants Member Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at their Measurement [Line Items] Disaggregation of Revenue [Table] Total revenue Research and development revenue Revenues Financial Instruments [Domain] Other U.S. governmental authorities [Member] Other USGovernmental Authorities Member Measurement Input Type [Axis] Statistical Measurement [Axis] Minimum [Member] Minimum [Member] Strike price (per share) [Member] Measurement Input, Share Price [Member] Volatility (annual) [Member] Measurement Input, Price Volatility [Member] Dividend yield (per share) [Member] Measurement Input, Expected Dividend Rate [Member] Class of Warrant or Right [Axis] Fair value measurements inputs Warrants and Rights Outstanding, Measurement Input Schedule of Revenues Disaggregated [Abstract] Financial Instrument [Axis] BARDA [Member] BARDAMember Schedule of Revenues Disaggregated [Line Items] Research and Development Revenue [Line Items] Research and Development Revenue [Abstract] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] BARDA Contract [Member] BARDAContract Member Under the Contract with an Overall Value [Member] Under The Contract With An Overall Value Member Amount received from contract Contract with Customer, Liability Fair Value Measurement Inputs and Valuation Techniques [Table] Statistical Measurement [Domain] Maximum [Member] Maximum [Member] Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs At Their Measurement [Abstract] Measurement Input Type [Domain] Research and Development Revenue (Details) [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Partnership With BARDA [Member] Partnership With BARDAMember Development costs Development Cost Amount of development cost. Cost of revenue Cost of revenue Cost of Revenue Research and development expense Other Research and Development Expense Convertible Promissory Notes [Member] Convertible Promissory Notes Member Equity financing, amount raised from institutional investors Equity Financing Amount Raised From Institutional Investors Equity financing, amount raised from institutional investors. Prime rate plus interest rate Prime Rate Plus Interest Rate The percentage of accrued interest prime rate plus interest rate. Related Party Transaction [Axis] Second Tranche [Member] Second Tranche Member Conversion amount Debt Conversion, Original Debt, Amount Warrant issued (in Shares) Warrants issued Debt Conversion, Converted Instrument, Warrants or Options Issued Exercise price per share (in Dollars per share) Exercise price per Class of Warrant or Right, Exercise Price of Warrants or Rights Cash and cash equivalents Cash Related and Nonrelated Parties [Domain] Class of Stock [Domain] Short-Term Debt, Type [Axis] Yorkville Convertible Notes [Member] Yorkville Convertible Notes Member Debt Instrument, Name [Domain] Notes Payable [Abstract] Final payment of accrued debt Debt Instrument, Increase, Accrued Interest Notes Payable (Details) [Table] Schedule of Accrued Expenses [Abstract] Operating expenses Accrued Operating Expenses Amount of accrued operating expenses. Non-operating expenses Accrued Nonoperating Expenses The amount of accrued non operating expenses. Equity Components [Axis] Common Stock [Member] Common Stock [Member] Common Stock Common stock, shares authorized Common stock, shares authorized (in Shares) Common Stock, Shares Authorized Preferred stock, shares authorized Preferred stock, shares authorized (in Shares) Preferred Stock, Shares Authorized Stock-Based Compensation (Details) [Table] 2023 Plan [Member] Two Thousand Twenty Three Long Term Incentive Plan Member Available for grant (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Recognized over a weighted-average period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Class of Stock [Axis] Common Stock, par value $0.0001 per share Common Stock Par Value00001 Per Share Member Stock Options [Member] Stock options [Member] Plan Name [Domain] Entity Central Index Key Current Fiscal Year End Date Entity Current Reporting Status Entity File Number Entity Emerging Growth Company Entity Small Business Schedule of RSU Activities [Abstract] Schedule of RSU Activities [Line Items] Stock-Based Compensation - Schedule of RSU Activities (Details) [Line Items] Number of Shares, Nonvested Beginning Number of Shares, Nonvested Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Stock-Based Compensation - Schedule of Stock Options Activity (Details) [Table] Stock Options, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Weighted Average Remaining Contractual Life (in years), Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Number of Shares, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Vested shares Vested shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Address, Address Line Two Entity Address, State or Province Entity Address, Postal Zip Code Local Phone Number Trading Symbol Title of 12(b) Security Other current assets Other Assets, Current Stockholders’ Deficit [Abstract] Equity Component [Domain] Common stock par value Common stock, par value (in Dollars per share) Common Stock, Par or Stated Value Per Share Weighted Average Exercise Price, Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Aggregate Intrinsic Value, Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Weighted Average Exercise Price, Options granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Options forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Options cancelled Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Schedule of Computation of Net Loss Per Common Share [Abstract] Antidilutive Securities [Axis] Common stock options [Member] Equity Option [Member] Document Information [Line Items] Document Quarterly Report Entity Interactive Data Current Inventory Inventory, Net Preferred stock, par value Preferred stock, par value (in Dollars per share) Preferred Stock, Par or Stated Value Per Share Stock-Based Compensation [Abstract] RSU [Member] Unvested restricted stock units [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Schedule of Stock-Based Compensation Expense [Line Items] Schedule of Stock Options Activity [Line Items] Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Cover [Abstract] Redeemable warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $2.75 Redeemable Warrants Each Whole Warrant Exercisable For One Share Of Common Stock At An Exercise Price Of275 Member Plan Name [Axis] Entity Registrant Name Entity Tax Identification Number Entity Filer Category Entity Shell Company Entity Ex Transition Period Entity Incorporation, State or Country Code Total current assets Assets, Current Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Other assets Other Assets, Noncurrent Commitments and contingencies (Note 7) Commitments and Contingencies Current liabilities: Liabilities, Current [Abstract] Accrued expenses Total accrued expenses Accrued Liabilities, Current Lease liabilities, long-term Operating Lease, Liability, Noncurrent Stockholders’ Deficit Equity, Attributable to Parent [Abstract] Lease liabilities, short-term Operating Lease, Liability, Current Warrant liabilities Derivative Liability, Current Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Total Stockholders’ Deficit Balance Balance Equity, Attributable to Parent Common stock ($0.0001 par value); 80,000,000 shares authorized; 32,184,928 and 30,688,895 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Common stock, shares issued (in Shares) Common Stock, Shares, Issued Document Period End Date Document Fiscal Period Focus Statement of Financial Position [Abstract] Current assets: Assets, Current [Abstract] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Prepaid expenses Prepaid Expense, Current Total Assets Assets Liabilities and Stockholders’ Equity (Deficit) Liabilities and Equity [Abstract] Accounts payable Accounts Payable, Current Deferred revenue Balance at ending Balance at beginning Contract with Customer, Liability, Current Notes payable, long-term Long-Term Debt, Excluding Current Maturities Total Liabilities Liabilities Notes payable Less: current portion of notes payable Notes Payable, Current Total current liabilities Liabilities, Current Preferred stock ($0.0001 par value); 1,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Preferred Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated deficit Retained Earnings (Accumulated Deficit) Total Liabilities and Stockholders’ Deficit Liabilities and Equity Common stock, shares outstanding (in Shares) Common Stock, Shares, Outstanding Common stock warrants [Member] Warrant [Member] Schedule of Computation of Net Loss Per Common Share [Line Items] Grant date fair value Assets, Fair Value Disclosure, Total Convertible notes payable [Member] Convertible Notes Payable [Member] Title and Position [Axis] Title and Position [Domain] Schedule of Stock Options Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Net (Loss) Income Per Common Share [Abstract] Net loss per share of common stock Schedule of Computation of Net Loss Per Common Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Company's Contract Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Accrued Expenses [Abstract] Ongoing partnership Ongoing Partnership Amount Ongoing partnership amount. Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Basis of Presentation Basis of Presentation and Significant Accounting Policies [Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] NET (LOSS) INCOME PER COMMON SHARE Earnings Per Share [Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] Nature of the Business and Presentation (Details) [Table] Food and Drug Administration [Member] Food And Drug Administration Member Prepaid expenses Increase (Decrease) in Prepaid Expense Sale of common stock (net of $19K issuance costs) Stock Issued During Period Value Sale Of Common Stock And Prefunded Warrants Amount of common stock and pre funded warrants. Stock option exercises Stock Issued During Period, Value, Stock Options Exercised Liquidity Liquidity Policy Text Block Disclosure of accounting policy for liquidity. Recently Issued Accounting Standards Recently Issued Accounting Standards Policy Text Block Disclosure of recently issued accounting standards policy text block. Schedule of Accrued Expenses Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of RSU Activities Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of Revenues Disaggregated Disaggregation of Revenue [Table Text Block] Customer One [Member] Customer One Member Accounts Receivable [Member] Accounts Receivable [Member] Nature of the Business and Presentation [Line Items] Change in Accounting Estimate [Line Items] Allowance for credit loss Accounts Receivable, Allowance for Credit Loss Selling and marketing Selling and Marketing Expense, Total Issuance of common stock under the SEPA Stock Issued During Period, Value, New Issues Issuance of common stock under the SEPA (in Shares) Stock Issued During Period, Shares, New Issues Warrant exercises (in Shares) Stock Issue During Period Shares Exercise Of Warrants Represents the shares of exercise of warrant. Warrant exercises Stock Issue During Period Value Exercise Of Warrants Represents the amount of exercise of Warrant. Decreased financing related costs Decreased Financing Related Costs Decreased financing related costs. Warrant Liabilities [Abstract] WARRANT LIABILITIES Warrant Liabilities [Text Block] The entire disclosure of warrant Liabilities. Schedule of Financial Liabilities that are Measured at Fair Value on a Recurring Basis Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Changes in Level 3 Liabilities Measured at Fair Value Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at their Measurement Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Commitments and Contingencies [Abstract] Related operating lease liability Operating Lease, Liability Classified short-term Short-Term Debt, Total Undiscounted lease payments Undiscounted Lease Payments Undiscounted lease payments. Material changes lease obligations Material Changes Lease Obligations Material changes to the Company’s lease obligations. Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Share-Based Payment Arrangement, Disclosure [Abstract] Customer [Axis] Statement of Stockholders' Equity [Abstract] Preferred stock, shares issued (in Shares) Preferred Stock, Shares Issued Gross profit Gross Profit General and administrative General and Administrative Expense Operating loss Operating Income (Loss) Net interest expense Interest Expense, Nonoperating Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net loss Net loss Basic (in Dollars per share) Earnings Per Share, Basic Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Basic [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Change in fair value of notes payable Change In Fair Value Of Notes Payable Amount of adjustment to fair value of notes payable. Total other income (expense), net Nonoperating Income (Expense) Deferred revenue Increase (Decrease) in Contract with Customer, Liability Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Noncash investing and financing activities disclosure: Noncash Investing and Financing Items [Abstract] Issuance of common stock to settle notes payable Issuance Of Common Stock To Settle Accounts And Notes Payable Issuance of common stock to settle accounts and notes payable. NATURE OF THE BUSINESS AND PRESENTATION Nature of Operations [Text Block] Recent Accounting Pronouncements [Abstract] ACCRUED EXPENSES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Proceeds from notes payable Proceeds from Notes Payable Description of operating segment Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Number of operating segment Number of Operating Segments Income Taxes [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Effective tax rate Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent U.S. federal statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Income tax expense Income tax provision Income Tax Expense (Benefit) Income Tax Contingency [Table] Geographical [Axis] Geographical [Domain] United States [Member] UNITED STATES Income Tax Contingency [Line Items] Long-term debt Other Long-Term Debt Concentration Risk Benchmark [Domain] Revenue Benchmark [Member] Revenue Benchmark [Member] Notes payable Other Notes Payable Concentration risk, percentage Concentration Risk, Percentage Related and Nonrelated Parties [Axis] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Initial award amount Government Assistance, Award Amount Contract description Research and Development Arrangement, Contract to Perform for Others, Description and Terms Increased net interest expense Interest Expense, Operating and Nonoperating, Total Undiscounted operating lease payments Operating Lease, Payments Sale of Stock [Axis] Sale of Stock [Domain] Private Placement [Member] Public Warrants [Member] Public Warrants Member Pre-Funded Warrants [Member] Pre Funded Warrants Member Stockholders’ Deficit (Details) [Table] Pre-funded warrant Pre-funded warrant exercises (in Shares) Stock Issued During Period Shares Prefunded Warrant Exercises Number of shares of stock issued attributable to transactions classified as pre-funded warrant exercises. Maturity date Debt Instrument, Maturity Date Schedule Of Companys Contract Liabilities Abstract Liability Class [Axis] Deferred revenue [Member] Deferred Revenue Member Reductions Contract With Customer Liability Reductions Represents contract with customer liability reductions. Contract assets: Change in Contract with Customer, Asset [Abstract] Additions Contract with Customer, Asset, Increase (Decrease) for Contract Acquired in Business Combination Balance at ending Balance at beginning Contract with Customer, Asset, after Allowance for Credit Loss Outstanding Balance Debt Instrument, Face Amount Unamortized debt discounts and debt issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Long-term debt, initial draw-down value Longterm Debt Financing Agreement Initial Drawdown Value Long-term debt financing agreement, initial draw-down value. Debt financing agreement, maximum borrowing capacity Debt Financing Agreement Maximum Borrowing Capacity Debt financing agreement, maximum borrowing capacity. Interest rate Debt Instrument, Interest Rate During Period Related Party Transaction [Domain] Debt Instrument [Line Items] Conversion percentage Debt Conversion, Converted Instrument, Rate Percentage of total funding Line of Credit Facility, Commitment Fee Percentage Debt payment Debt Instrument, Periodic Payment, Principal Settled in shares Repayment Of Debt Value Settled In Shares Represent the amount of repayment of debt settled in shares value. Stockholders’ Deficit [Line Items] Schedule of Company's Contract Liabilities [Table] Research and Development Revenue - Schedule of Company's Contract Liabilities (Details) [Table] Fair Value by Liability Class [Domain] Reductions Contract With Customer Assets Reductions The amount of reduction. Unbilled revenue [Member] Unbilled Revenues [Member] Contract liabilities: Contract with Customer, Liability [Abstract] Additions Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination Salary and wages Accrued Salaries, Current Benefits Accrued Employee Benefits, Current Taxes Accrued Income Taxes, Current Short-Term Debt, Type [Domain] Debt Instrument [Axis] Avenue Capital Financing [Member] Avenue Capital Financing Member Notes Payable - Schedule of Avenue Financing and Financing Arrangements (Details) [Table] Yorkville Convertible Notes, at fair value [Member] Yorkville Convertible Notes At Fair Value Member 2024 Insurance Note [Member] Two Thousand Twenty Four Insurance Note Member Directors and Officers [Member] Directors And Officers Member Amount Financed Financed Insurance Note The amount of financed insurance note. Principal Repayments Debt Instrument, Repaid, Principal Notes payable. long term Notes Payable, Noncurrent Received net proceeds Proceeds from Issuance Initial Public Offering Yorkville SEPA [Member] Shares registered for resale in connection Shares Registered for Resale in Connection Shares registered for resale in connection. Available under its effective shelf registration Available Under Effective Shelf Registration Available under its effective shelf registration. Schedule of Company's Contract Liabilities [Line Items] Schedule of Company's Contract Liabilities [Line Items] Schedule Of Avenue Financing And Financing Arrangements Abstract Avenue Capital Note Principal and Final Payment Fee [Member] Avenue Capital Note Principal And Final Payment Fee Member 2025 Insurance Note [Member] Two Thousand Twenty Five Issuance Note Member Schedule of Avenue Financing and Financing Arrangements [Line Items] Interest Rate Debt Instrument, Interest Rate, Effective Percentage Potentially dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Document Type Document Transition Report Stock-Based Compensation - Schedule of RSU Activities (Details) [Table] Weighted Average Grant Date Fair Value per Share, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value per Share, Nonvested Beginning Weighted Average Grant Date Fair Value per Share, Nonvested Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value per Share, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Schedule Of Stock Options Activity Abstract Weighted Average Exercise Price, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Weighted Average Grant Date Fair Value per Share, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Non-current assets: Assets, Noncurrent [Abstract] Right-of-use assets Operating Lease, Right-of-Use Asset Shares of common stock Aggregate shares Sale of Stock, Number of Shares Issued in Transaction Gross proceeds Proceeds from Issuance or Sale of Equity, Total Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Weighted Average Exercise Price, Options exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Granted shares of restricted stock Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Remaining vested shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested Remaining in Period The number of grants made during the period on other than stock (or unit) option plans remaining (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Stock Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Weighted Average Remaining Contractual Life (in years), Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term Stock Options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Stock Options forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Stock Options cancelled Share Based Compensation Arrangementby Share Based Payment Award Options Cancelledin Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Stock Options exercised Stock option exercises (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Schedule of Computation of Net Loss Per Common Share [Table] Antidilutive Securities, Name [Domain] Amendment Flag Document Fiscal Year Focus Assets Assets [Abstract] Entity Address, Address Line One Entity Address, City or Town City Area Code Entity Common Stock, Shares Outstanding Security Exchange Name Document Information [Table] Chief Executive Officer [Member] Advancement of contract Advance Amount Received Advance amount received. Contract with an overall value Contract Amount Amount of contract overall value. STOCKHOLDERS’ DEFICIT Equity [Text Block] Nature of the Business and Presentation [Abstract] Principles of Consolidation Consolidation, Policy [Policy Text Block] Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Subsequent Events [Abstract] Customer [Domain] Contract value Contract Value Amount of contract initial award value. Contract additional value Contract Additional Value The amount of contract additional total value. Cash and cash equivalents Cash and Cash Equivalent Development costs Business Development Stock-based compensation APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Issuance of Common Stock from debt offering (in Shares) Stock Issued During Period, Shares, Other Issuance of common stock to pay convertible debt (in Shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Deficit Retained Earnings [Member] Vesting of restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Gross Cumulative translation adjustment Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) Net of issuance costs Issuanceof Costs Net Amount Issuance of common stock net of issuance costs. Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Amortization of debt issuance costs Amortization of Debt Issuance Costs Amortization of right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Change in fair value of notes payable Change In Fair Values Of Notes Payable Change in fair value of notes payable. Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Inventory Increase (Decrease) in Inventories Sale of common stock (net of $19K issuance costs) (in Shares) Stock Issued During Period Shares Sale Of Common Stock And Prefunded Warrantsin Shares Number of share options (or share units) exercised during the current period. Risks and Uncertainties Risks And Uncertainties Policy Text Block Disclosure of accounting policy for risks and uncertainties. Recently Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Avenue Financing and Financing Arrangements Convertible Debt [Table Text Block] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Statement Of Income Balance [Axis] Statement of Income, Balance [Domain] Research and Development [Member] General and Administrative [Member] Selling and Marketing [Member] Total stock-based compensation expense Share-Based Payment Arrangement, Expense Stock option exercises Proceeds From Stock Option Exercised Proceeds from stock option exercised. Basic (in Shares) Weighted Average Number of Shares Outstanding, Basic Other comprehensive income (loss): Other Comprehensive Income (Loss), Tax [Abstract] Total comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Diluted (in Shares) Weighted Average Number of Shares Outstanding, Diluted Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Statement [Table] Statement [Line Items] Balance (in Shares) Balance (in Shares) Shares, Outstanding Issuance of Common Stock from debt offering Stock Issued During Period, Value, Other Issuance of common stock to pay convertible debt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Vesting of restricted stock units (in Shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Pre-funded warrant exercises Stock Issued During Period Value Prefunded Warrant Exercises Value of shares of stock issued attributable to transactions classified as pre-funded warrant exercises. Sale of common stock net of issuance costs Sale Of Net Issuance Costs Amount of sale of common stock and pre-funded warrants net issuance costs. Statement of Cash Flows [Abstract] Depreciation expense Depreciation Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Change in fair value of warrant liabilities Change in fair value of warrant liability Fair Value Adjustment of Warrants Issuances of shares for borrowing related costs Issuances Of Shares For Borrowing Related Costs Issuances of shares for borrowing related costs. Accounts receivable Increase (Decrease) in Accounts Receivable Operating costs and expenses: Operating Costs and Expenses [Abstract] Total operating costs and expenses Operating Expenses Other income (expense): Other Nonoperating Income (Expense) [Abstract] Financing related costs Financing Interest Expense Preferred stock, shares outstanding (in Shares) Preferred Stock, Shares Outstanding Income Statement [Abstract] Diluted (in Dollars per share) Earnings Per Share, Diluted Other assets Increase (Decrease) in Other Operating Assets Foreign exchange transaction loss, net Gain (Loss), Foreign Currency Transaction, before Tax Proceeds from issuance of common stock and warrants Proceeds from Issuance of Common Stock Accrued expenses Increase (Decrease) in Accrued Liabilities Lease liabilities Increase (Decrease) in Operating Lease Liability Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Cash paid for taxes Income Tax Paid, before Refund Received Tenant improvement allowance payments made by the lessor directly to a third party Tenant Improvement Allowance Payments Made By The Lessor Directly To AThird Party Tenant improvement allowance payments made by the lessor directly to a third party. RECENT ACCOUNTING PRONOUNCEMENTS Significant Accounting Policies [Text Block] RESEARCH AND DEVELOPMENT REVENUE Revenue from Contract with Customer [Text Block] NOTES PAYABLE Debt Disclosure [Text Block] Payments for notes payable Repayments of Notes Payable Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Research and development Research and Development Expense, Total Segment Information [Abstract] SEGMENT INFORMATION Segment Reporting [Text Block] Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] SP Angel Corporate Finance LLP (“SP Angel”) [Member] SP Angel Corporate Finance LLP SP Angel [Member] Concentration Risk Type [Domain] Warrants Details [Table] Warrant Liabilities [Line Items] Class of Warrant or Right [Line Items] Warrants issuance term Warrants and Rights Outstanding, Term Warrants outstanding (in Shares) Class of Warrant or Right, Outstanding Common stock exercise price (in Dollars per share) Stock Option, Exercise Price, Increase Strike price Derivative, Average Price Risk Option Strike Price Offering price Sale of Stock, Price Per Share Exercise price Warrant, Exercise Price, Increase Exercise of warrants of increase Exercise Of Warrants Of Increase Exercise of warrants of increase. Initial draw-down amount Initial Drawdown Amount Initial draw-down amount. Warrants purchase shares Class of Warrant or Right, Number of Securities Called by Warrants or Rights Funding commitment Funding Commitment Percentage Percentage of total funding commitment. Purchase price per share Purchase Price Per Share Number of pre fund warrant purchase per share. Fair Value Measurements - Schedule of Financial Liabilities that are Measured at Fair Value on a Recurring Basis (Details) [Table] Fair Value Measurements - Schedule of Financial Liabilities that are Measured at Fair Value on a Recurring Basis (Details) [Table] Schedule Of Financial Liabilities That Are Measured At Fair Value On ARecurring Basis [Abstract] Schedule of Financial Liabilities that are Measured at Fair Value on a Recurring Basis [Line Items] Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member]